We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| BioXcel Therapeutics Inc | NASDAQ:BTAI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.39% | 2.57 | 2.58 | 2.71 | 2.6701 | 2.56 | 2.60 | 147,562 | 00:48:43 |
From May 2019 to May 2024
Conference Call & Webcast Details
Date/Time: Monday, March 9, 2020, 8:30 AM Eastern TimeDomestic: 877-407-2985International: 201-378-4915
The webcast will be accessible* under "Events" on the News & Media page of the Company's website at www.bioxceltherapeutics.com.
ReplayDomestic: 877-660-6853International: 201-612-7415Conference ID: 13696573
*Replay available through March 23, 2020
About BioXcel Therapeutics, Inc.:
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BTI's drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BTI's two most advanced clinical development programs are BXCL501, an investigational sublingual thin film formulation in development for acute treatment of agitation resulting from neuropsychiatric disorders, and BXCL701, an investigational orally administered systemic innate immunity activator in development for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer in combination with other immuno-oncology agents. For more information, please visit www.bioxceltherapeutics.com.
Contact Information:
BioXcel Therapeutics, Inc.www.bioxceltherapeutics.com
Investor Relations: John Graziano jgraziano@troutgroup.com1.646.378.2942
Media: Julia Deutsch jdeutsch@troutgroup.com1.646.378.2967
1 Year BioXcel Therapeutics Chart |
1 Month BioXcel Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
